SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH METHOTREXATE AND HYDROXYCHLOROQUINE MONOTHERAPIES OR COMBINATION THERAPY

被引：0
|
作者：
Velthuis, K. [1 ]
Nguyen, M. [1 ]
Scholl, J. [1 ]
Jansen, J. [1 ]
Van Lint, J. [1 ]
Ten Klooster, P. [2 ,3 ]
Vonkeman, H. [3 ,4 ]
Jessurun, N. [1 ]
机构：
[1] Netherlands Pharmacovigilance Ctr Lareb, Res Dept, sHertogenbosch, Netherlands
[2] Transparency Healthcare BV, Hengelo, Netherlands
[3] Univ Twente, Dept Psychol Hlth & Technol, Enschede, Netherlands
[4] Medisch Spectrum Twente, Dept Rheumatol & Clin Immunol, Enschede, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0648
引用
收藏
页码：562 / 563
页数：2
相关论文
共 50 条
  • [1] SURVIVAL ANALYSIS OF TIME TO FIRST ADVERSE DRUG REACTION AND DRUG SURVIVAL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND ETANERCEPT
    Nguyen, M.
    Velthuis, K.
    Scholl, J.
    Jansen, J.
    Kosse, L.
    Ten Klooster, P.
    Jessurun, N.
    Vonkeman, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1122 - 1122
  • [2] METHOTREXATE DRUG SURVIVAL AND ADVERSE EFFECTS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Kearsley-Fleet, L.
    Gonzalez, L. Vicente
    Steinke, D.
    Davies, R.
    De Cock, D.
    Baildam, E.
    Beresford, M. W.
    Foster, H. E.
    Southwood, T. R.
    Thomson, W.
    Hyrich, K. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 493 - 493
  • [3] DRUG SURVIVAL ANALYSIS OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Karakoc, Y.
    Ercan, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1411 - 1411
  • [4] The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug
    Soderlin, M. K.
    Petersson, I. F.
    Geborek, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (01) : 1 - 9
  • [5] SURVIVAL AND DRUG DISCONTINUATION ANALYSES IN A LARGE COHORT OF METHOTREXATE-TREATED RHEUMATOID-ARTHRITIS PATIENTS
    ALARCON, GS
    TRACEY, IC
    STRAND, GM
    SINGH, K
    MACALUSO, M
    ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (09) : 708 - 712
  • [6] First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept
    Velthuis, Kimberly
    Jessurun, Naomi T.
    Nguyen, Thi D. M.
    Scholl, Joep
    Jansen, Jurriaan R. G.
    van Lint, Jette A.
    Kosse, Leanne J.
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (06) : 485 - 492
  • [7] The effects of methotrexate and hydroxychloroquine combination therapy vs methotrexate monotherapy in early rheumatoid arthritis patients
    Schapink, Lisa
    van den Ende, Cornelia H. M.
    Gevers, Laura A. H. A.
    van Ede, Annelies E.
    den Broeder, Alfons A.
    RHEUMATOLOGY, 2019, 58 (01) : 131 - 134
  • [8] bDMARD Drug Survival in Combination Therapy with Methotrexate in Psoriatic Arthritis: A Systematic Literature Review and Meta-analysis
    Hanna Abdelmassih, Selina
    Dujardin, Tiphaine
    Baillet, Athan
    Gaudin, Philippe
    Romand, Xavier
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1217 - 1219
  • [9] Sepsis as a possible adverse drug reaction in patients with rheumatoid arthritis treated with TNFα antagonists
    Kling, A
    Mjörndal, T
    Rantapää-Dahlqvist, S
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2004, 10 (03) : 119 - 122
  • [10] Drug survival in psoriatic patients treated with biologic agent for the first time
    Mitratza, Marianna
    Papadavid, Evangelia
    Bamia, Christina
    Theodoropoulos, Konstantinos
    Katsimbri, Pelagia
    Boumbas, Dimitrios
    Rigopoulos, Dimitrios
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB106 - AB106
12345